ARCHIVES

FDA Committee Agenda Includes M-AMSA, THC, Estramustine, Platinum

This article is from The Cancer Letter archive.

Vol. 07 No. 21 | May 22, 1981

Download PDF Visit The Full Archive

Related Articles

ACS Adopts Principles As Basis For Reform Of Health Care System

July 17, 1992

The March: AACR, AACI Compile List Of Activities Related To The March

May 8, 1998

Racial Differences In Survival Increase According To Stage

August 31, 2007

Arimidex Continues To Show Improvement Over Tamoxifen

December 27, 2002

NCAB Seeks Exemption From New Reimbursement Plan For Clinical Trials, Modification Of Hospice Regs

February 11, 1983

DCPC Board Commits More Than $100 Million To 15-Year Trial Of Low Fat Diet In Women

October 26, 1990